Patents Assigned to Bayer
  • Patent number: 11504932
    Abstract: The invention concerns a die insertion tool (100) for inserting a die (550) into a die pocket (552) of a press (500), the tool (100) includes a barrel (102) shaped for positioning the tool (100) within a punch guide bore (582) of the press (500), a tip (106) for insertion into a die cavity (556) of the die (550), and a collar (104) located between the barrel (102) and the tip (106) and configured to contact the die (550) when the tip (106) is inserted in the die cavity (556). The invention further concerns a kit (700) for a press (500) and a method for inserting a die (550) into a die pocket (552) of a press (500).
    Type: Grant
    Filed: November 27, 2018
    Date of Patent: November 22, 2022
    Assignee: BAYER HEALTHCARE LLC
    Inventor: Michael Klopp
  • Patent number: 11505553
    Abstract: The invention relates to novel compounds of the formula (I) in which R1, Ra, Rb, Rc, R3, R4, A1, A2 and n have the definitions given above, to agrochemical formulations comprising the compounds of formula (I) and to their use as acaricides and/or insecticides for controlling animal pests, particularly arthropods and especially insects and arachnids.
    Type: Grant
    Filed: April 25, 2018
    Date of Patent: November 22, 2022
    Assignee: BAYER AKTIENGESELLSCHAFT
    Inventors: Marc Mosrin, Ruediger Fischer, Dominik Hager, Laura Hoffmeister, Nina Kausch-Busies, David Wilcke, Matthieu Willot, Kerstin Ilg, Daniela Portz, Ulrich Goergens, Sascha Eilmus, Andreas Turberg
  • Patent number: 11505545
    Abstract: The present invention covers new quinoline compounds of general formula (I): in which A, R1, R2, R3, R4, R5, R6, and Q are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment, control and/or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients.
    Type: Grant
    Filed: October 30, 2020
    Date of Patent: November 22, 2022
    Assignee: Bayer Animal Health GmbH
    Inventors: Walter Hübsch, Johannes Köbberling, Adeline Köhler, Hans-Georg Schwarz, Daniel Kulke, Claudia Welz, Thomas Ilg, Kirsten Börngen, Wei Zhuang, Nils Griebnow, Claudia Böhm, Niels Lindner, Maike Hink, Ulrich Görgens
  • Patent number: 11505544
    Abstract: The present invention relates to a new process for preparing quinoline compounds of the general formula (II): in which Q, A, R4, R3 and R3?, are as defined herein, as well as to the intermediate compounds of said new process.
    Type: Grant
    Filed: December 14, 2018
    Date of Patent: November 22, 2022
    Assignee: Bayer Animal Health GMBH
    Inventors: Florian Erver, Frank Memmel, Thomas Himmler, Andreas Karl Steib, Marc Nowakowski
  • Publication number: 20220366273
    Abstract: The present invention is concerned with the predicting of crop protection product residues in plants or parts of plants intended for human and/or animal consumption, preferably in fruit and/or vegetables. The present invention provides a method, a device, a system and a computer program product for prediction of crop protection product residues.
    Type: Application
    Filed: August 4, 2020
    Publication date: November 17, 2022
    Applicant: Bayer Aktiengesellschaft
    Inventors: Kai WIRTZ, Rolf Christian BECKER, Linus GOERLITZ, Dirk SCHAEFER, Fabian WEYSSER
  • Publication number: 20220357481
    Abstract: An information processing device is configured to acquire prediction information of a weather condition outside a plastic greenhouse and cultivation information of produce inside the plastic greenhouse and predict an environmental condition inside the plastic greenhouse based on the prediction information of the weather condition and the cultivation information. Cultivation information includes at least one item of information from among the type of produce, a cultivation amount, a growth state, and a cultivation ground. A prediction model may be generated with machine learning.
    Type: Application
    Filed: May 29, 2020
    Publication date: November 10, 2022
    Applicant: Bayer CropScience K.K.
    Inventors: Satoshi ITO, Victoria SMART, Mehul BANSAL
  • Publication number: 20220356194
    Abstract: A process for preparing the benzothiophen-2-yl boronate of formula (VI) which serves as an intermediate for production of medicaments and for production of medicaments for treatment and/or prophylaxis of proliferative disorders, such as cancer and tumor diseases.
    Type: Application
    Filed: March 10, 2022
    Publication date: November 10, 2022
    Applicant: Bayer Pharma Aktiengesellschaft
    Inventors: Jörg GRIES, Johannes PLATZEK
  • Patent number: 11491245
    Abstract: A compound having the formula of tetragadolinium [4,10-bis(carboxylatomethyl)-7-{-3,6,12,15-tetraoxo-16-[4,7,10-tris(carboxylatomethyl)-1,4,7,10-tetraazacyclododecan-1-yl]-9,9-bis({[({2-[4,7,10-tris(carboxylatomethyl)-1,4,7,10-tetraazacyclododecan-1-yl]propanoyl}amino)acetyl]amino}methyl)-4,7,11,14-tetraazaheptadecan-2-yl}-1,4,7,10-tetraazacyclo dodecan-1-yl]acetate wherein the stereochemistry at the chiral carbon of the four alanine substituents is selected from the group consisting of RRRR, SSSS, RSSS, RRSS, and RRRS stereoisomers, and racemic and diastereomeric mixtures of any thereof, or a tautomer, a hydrate, a solvate, or a salt thereof, or a mixture of same is described. The compounds may be used as an MRI contrast imaging agent.
    Type: Grant
    Filed: July 27, 2020
    Date of Patent: November 8, 2022
    Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Markus Berger, Jessica Lohrke, Christoph-Stephan Hilger, Gregor Jost, Thomas Frenzel, Detlev Suelzle, Johannes Platzek, Olaf Panknin, Hubertus Pietsch
  • Patent number: 11492358
    Abstract: The present invention relates to macrocyclic indole derivatives of general formula (I) in which R1, R2, R3, R4, R5, R6, A and L are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of hyperproliferative disorders, as a sole agent or in combination with other active ingredients.
    Type: Grant
    Filed: February 26, 2021
    Date of Patent: November 8, 2022
    Assignees: The Broad Institute, Inc., Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft
    Inventors: Sarah Anna Liesa Johannes, Philipp Buchgraber, Ulrich Klar, Clara Christ, Kai Thede, Joachim Kuhnke, Manfred Moewes, Knut Eis, Amaury Ernesto Fernandez-Montalvan, Nicolas Werbeck, Ursula Mönning, Philip Lienau, Ulrike Sack, Arne Scholz, Michael H. Serrano-Wu, Christopher Lemke, David McKinney, Mark Fitzgerald, Christopher Nasveschuk, Kiel Lazarski, Steven James Ferrara, Laura Furst, Guo Wei, Patrick Ryan McCarren
  • Patent number: 11492770
    Abstract: An apparatus and a method for increasing the movement speed of the rail vehicle while carrying out measures for controlling weeds on track systems. A rail vehicle equipped with an apparatus for increasing the movement speed of the rail vehicle while carrying out measures for controlling weeds on track systems.
    Type: Grant
    Filed: May 11, 2018
    Date of Patent: November 8, 2022
    Assignee: Bayer Aktiengesellschaft
    Inventor: Hinnerk Bassfeld
  • Patent number: 11490624
    Abstract: Water-based formulations (EW) are provided containing no VOC's or alternatively are low in VOC's for wide area space spray to control mosquitoes, flies, and other public health pests. Application via ULV, these formulations have been observed to provide significantly superior control of pests when compared to competitive adulticides. The present formulations provide exceptional preservation of both droplet density in the spray cloud and droplet size as measured by volume mean diameter (VmD). The present formulations provide superior bio-efficacy as measured by both mortality and knockdown of target organisms. The present formulations provide superior biological control, droplet density, and droplet size when applied at concentrations 20-80× less than competitive formulations.
    Type: Grant
    Filed: February 18, 2020
    Date of Patent: November 8, 2022
    Assignee: BAYER CROPSCIENCE LP
    Inventors: Robert Britt Baker, Kurt P. Vandock, Gary Gore, Byron Reid
  • Patent number: 11491318
    Abstract: A multi-use disposable set (MUDS) has at least one syringe having a proximal end and a distal end spaced apart from the proximal end along a longitudinal axis. The MUDS further has a plunger reciprocally movable within a syringe interior between the proximal end and the distal end. A manifold is in fluid communication with the distal end of the at least one syringe. At least one valve is in fluid communication with the syringe interior. The at least one valve is operable between a filling position for filling the syringe interior with fluid and a delivery position for delivering the fluid from the syringe interior. At least one connection port is in fluid communication with the manifold and the syringe interior when the at least one valve is in the delivery position. A multi-fluid delivery system having the medical connector and MUDS is also provided. Various features of the MUDS system are also described.
    Type: Grant
    Filed: December 13, 2019
    Date of Patent: November 8, 2022
    Assignee: BAYER HEALTHCARE LLC
    Inventors: John Haury, Michael Swantner, Richard Sokolov, Benjamin James Cullen, Alison Ruth Von Moger, Ernesto Hueso Monis, Kamman Law, Mark Silivio Profaca, Patrick Spence, Michael Spohn, Justin Angert, Brian Cain
  • Patent number: 11485733
    Abstract: The present invention covers azaquinoline compounds of general formula (I), with A being (A1) or (A2), and in which T, R1, R2, R3, R4, R5, R6 and Q are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment, control and/or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: November 1, 2022
    Assignee: BAYER ANIMAL HEALTH GMBH
    Inventors: Nils Griebenow, Wei Zhuang, Adeline Köhler, Daniel Kulke, Claudia Böhm, Kirsten Börngen, Thomas Ilg, Hans-Georg Schwarz, Werner Hallenbach, Ulrich Görgens, Walter Hübsch, Bernd Alig, Iring Heisler, Isa Jana Irina Janssen
  • Publication number: 20220339297
    Abstract: Methods and materials for effective dosages of AAV gene therapy for the treatment and prophylaxis of hemophilia A.
    Type: Application
    Filed: April 20, 2022
    Publication date: October 27, 2022
    Applicant: Bayer HealthCare LLC
    Inventors: Nicole Schmidt, Inge Ivens, Anita Shah, Konstantina Vanevski
  • Patent number: 11479565
    Abstract: The present invention relates to a process for preparing substituted imidazole derivatives of the formula (II) from compounds of the formula (I) via intermediates of the formula (IVa) or (IVb) in which the structural elements shown in the formulae (I), (II), (IVa) and (IVb) have the meanings given in the description. Furthermore, the invention relates to the intermediates of the formulae (IVa) and (IVb).
    Type: Grant
    Filed: October 9, 2019
    Date of Patent: October 25, 2022
    Assignee: Bayer Aktiengesellschaft
    Inventors: Matthieu Willot, Ruediger Fischer, Dominik Hager, Laura Hoffmeister, Marc Mosrin, David Wilcke
  • Patent number: 11477982
    Abstract: What are described are compounds of the general formula (I) and agrochemically acceptable salts thereof and their preparation and their use in the crop protection sector.
    Type: Grant
    Filed: March 29, 2018
    Date of Patent: October 25, 2022
    Assignees: BAYER CROPSCIENCE AKTIENGESELLSCHAFT, BAYER AKTIENGESELLSCHAFT
    Inventors: Harald Jakobi, Estella Buscato Arsequell, Klemens Minn, Uwe Doeller, Hansjoerg Dietrich, Elmar Gatzweiler, Anu Bheemaiah Machettira, Christopher Hugh Rosinger, Dirk Schmutzler
  • Patent number: D971021
    Type: Grant
    Filed: April 22, 2020
    Date of Patent: November 29, 2022
    Assignee: Bayer Healthcare LLC
    Inventors: Mark Kansburg, Graham Hufton
  • Patent number: D971022
    Type: Grant
    Filed: April 22, 2020
    Date of Patent: November 29, 2022
    Assignee: Bayer Healthcare LLC
    Inventors: Mark Kansburg, Graham Hufton
  • Patent number: D971431
    Type: Grant
    Filed: April 2, 2021
    Date of Patent: November 29, 2022
    Assignee: Bayer Consumer Care AG
    Inventor: Michael Best
  • Patent number: D971432
    Type: Grant
    Filed: April 2, 2021
    Date of Patent: November 29, 2022
    Assignee: Bayer Consumer Care AG
    Inventor: Michael Best